Author:
Konukoglu Ender,Glocker Ben
Funder
Alzheimer's Disease Neuroimaging Initiative
DOD ADNI
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
AbbVie
Alzheimers Association
Alzheimer's Drug Discovery Foundation
Araclon Biotech
BioClinica, Inc.
Biogen
Bristol-Myers Squibb Company
CereSpir, Inc.
Cogstate
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
EuroImmun
F. Hoffmann-La Roche Ltd
Genentech, Inc.
Fujirebio
GE Healthcare
IXICO Ltd.
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Johnson & Johnson Pharmaceutical Research & Development LLC.
Lumosity
Lundbeck
Merck & Co., Inc.
Meso Scale Diagnostics, LLC.
NeuroRx Research
Neurotrack Technologies
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Piramal Imaging
Servier
Takeda Pharmaceutical Company
Transition Therapeutics
The Canadian Institutes of Health Research
National Institutes of Health
Subject
Cognitive Neuroscience,Neurology
Reference40 articles.
1. M. R. Arbabshirani, S. Plis, J. Sui, V. D. Calhoun, Single subject prediction of brain disorders in neuroimaging: promises and pitfalls, Neuroimage.
2. Why voxel-based morphometry should be used;Ashburner;Neuroimage,2001
3. Visual feature attribution using wasserstein GANs;Baumgartner,2018
4. Il calcolo delle assicurazioni su gruppi di teste, Tipografia del Senato;Bonferroni,1935
5. Neuropathological stageing of Alzheimer-related changes;Braak;Acta Neuropathol.,1991
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献